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1. Introduction
　There is no doubt that the rapid growth in 
aging population becomes a major global concern, 
and this trend is expected to continue with a 
concurrent increase in age-related diseases (1). 
Aging, as an inevitable process, could lead to 
physiological functional decline in metabolic, 
respiratory, and exercise capacity associated with 
loss of skeletal muscle mass and strength, obesity, 
and many metabolic diseases, such as type 2 
diabetes (2-4). In skeletal muscle, aging process 
contributes to muscle weakness and increased 
fatigability (5), leading to impaired mobility and 
loss of independence in individuals (6). Maximal 
oxygen uptake (VO2max) declines with age, 
possibly due to a diminished capacity to deliver 
and extract O2 during exercise, in humans (7, 8). 
Further, compared to young rats (3-6 months old), 
spontaneous locomotor activity of aged rats (24-
27 months old) was found to be lower (9). Conley 
et al. (10) reported a 50% reduction in oxidative 
capacity in older human subjects compared to 
young subjects, due to reduced mitochondrial 
volume and reduced mitochondrial function. Age-
related impaired mitochondrial function in muscles 
is attributed to reduced mitochondrial DNA 
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aged 32 to 92 weeks. Our findings suggest that the aging process might contribute to a decline in the VO2, 
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32 weeks. With advancing age, skeletal muscle mass decreased significantly in rats aged 85 weeks (soleus 
muscle: 0.47 g/kg, gastrocnemius (Gas) muscle: 5.00 g/kg), and 92 weeks (soleus muscle: 0.50 g/kg, Gas 
muscle: 5.62 g/kg) compared to that in rats aged 32 weeks (soleus muscle: 0.70 g/kg, Gas muscle: 8.89 g/kg). 
With aging, the levels of genes Myh7, Ppargc1α, Cycs, and sdha, and mitochondrial DNA, which are related to 
skeletal muscle function and muscle oxidative capacity, decreased significantly in the soleus muscle of rats 
aged 85 and 92 weeks compared to that of rats aged 32 weeks. In addition, lipid accumulation in skeletal 
muscle and weight of white adipose tissue (WAT) around kidney increased with age in rats. This study may 
clarify age-related changes in energy metabolism, skeletal muscle characteristics, and lipid accumulation in 
rats, and provide a potential perspective for anti-aging research.
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content (11). Previous studies reported that the 
master regulator of metabolism and mitochondrial 
functions (12, 13), peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC-1
α ), decreased during aging (14). Aging is also 
associated with dysregulation of lipid metabolism. 
Honma showed that the weight of white adipose 
tissue (WAT) and levels of liver triacylglycerol, 
plasma free fatty acids (FFA), and plasma insulin 
showed an increase with aging in SAMP10 mice 
(15). Muscle RING-finger 1 (MuRF1), which is 
highly induced in atrophying muscle, may play an 
important role in the breakdown of myofibrillar 
proteins (16, 17). Atrogin-1 mRNA increases 8 
to 40-fold in atrophy study, and this increase 
precedes the onset of muscle weight loss (16, 18). 
Moreover, knockout animals lacking atrogin-1 
show a reduced rate of muscle atrophy after 
denervation (18). There may be various factors 
involved with the aging process. In this study, we 
further investigated age-related changes, including 
VO2, spontaneous locomotor activity, tissue weight, 
blood biochemical index, and gene expression in 
skeletal muscle of Sprague-Dawley (SD) rats aged 
32 to 92 weeks.
２．Materials and Methods
２．１　Materials
　Formalin, 2-mercaptoethanol, 1% eosin Y solution, 
and commercial assay kit for free fatty acid (FFA) 
(NEFA C-Test Wako), cholesterol (Cholesterol 
E-Test Wako) and Oil-Red O were purchased 
from FUJIFILM Wako Pure Chemical Corporation 
(Osaka, Japan). Ethanol and nitro blue tetrazolium 
were purchased from Sigma-Aldrich (St. Louis, 
MO, USA), and hematoxylin from Merck KGaA 
(Darmstadt, Germany). Mount-Quick and Mount-
Quick aqueous mounting media were purchased 
from Daido Sangyo Co., Ltd (Tokyo, Japan). 
Sepasol-RNA I Super G and sodium succinate were 
purchased from Nacalai Tesque (Kyoto, Japan). 
RNase inhibitor, ReverTra Ace® qPCR (quantitative 
polymerase chain reaction) Master Mix, and gDNA 
(genomic DNA) remover kit were purchased 
from TOYOBO Co., Ltd. (Osaka, Japan). KAPA 
SYBR® FAST qPCR kit was purchased from Kapa 
Biosystems (Wilmington, MA, USA). 
２．２　Animal experiments
　The care and use of the animals in this study 
followed the guidelines of Okayama Prefectural 
University and the laws and notifications of the 
Japanese government. All animal experiments 
were approved by the Animal Care and Use 
Committee of Okayama Prefectural University 
(protocol number 27-3). Male SD rats aged 32 
weeks (n=4-15) were obtained from Charles River 
Laboratories Japan, Inc. (Yokohama, Japan). They 
were housed individually in an air-conditioned 
room at 25 °C with an alternating 12 h light/dark 
cycle (light, 8:00-20:00). All rats were allowed free 
access to commercial food (CE-2, CLEA Japan, 
Inc., Tokyo, Japan) and water. Food intake and 
body weight were measured daily. Respiratory 
metabolism was measured with VO2 and CO2 
generation volumes, using a metabolism measuring 
system (MK-5000, Muromachi Kikai, Tokyo, Japan), 
and spontaneous locomotor activity was measured 
using an infrared sensor (SUPERMEX SENSOR 
PYS-001, Muromachi Kikai, Tokyo, Japan). Each 
rat was kept in a sealed chamber for 24 h at 25°C. 
The airflow was 3.0 L/min. The animals had free 
access to water and food. At the age of 32, 85, 
and 92 weeks, the rats were anesthetized by an 
intraperitoneal injection of pentobarbital sodium 
(100 μ L/100 g of body weight). Tissue were collected 
and stored at -80 °C until subsequent measurements. 
Blood samples were collected in heparinized tubes 
and centrifuged at 3,000 × g and 4 °C for 10 min 
and plasma was obtained. FFA and cholesterol in 
plasma were determined by commercial kit.
２．３　Histological analysis
　The soleus muscle was cut into 10 μ m sections using 
a Leica CM3050 S cryostat (Leica Microsystems, Wetzlar, 
Germany) at -20 °C and fixed in 10% (v/v) formalin. The 
sections were stained with hematoxylin and eosin 
(H&E) and mounted in Mount-Quick medium. The 
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sections were stained with Oil-Red O and mounted 
in Mount-Quick Aqueous medium. For succinate 
dehydrogenase (SDH) staining, the soleus sections 
were air-dried at room temperature and incubated 
in a solution consisting of 50 mM phosphate 
buffer (6 mM potassium dihydrogenphosphate and 
44 mM disodium hydrogenphosphate), 50 mM sodium 
succinate, and 0.5 mg/mL nitro blue tetrazolium at 
37 °C for 40 min. The sections were washed in double 
distilled H2O for 3 min and mounted in Mount-
Quick aqueous mounting medium. Images were 
captured with a CCD camera (Olympus Optical, 
Tokyo, Japan) at × 100 magnification.
２．４　qRT-PCR analysis
　Total RNA was isolated from frozen tissue with 
Sepasol-RNA I Super G. RNase inhibitor was added 
according to the manufacturer’s instructions. Total 
RNA was measured and cDNA was prepared 
using the ReverTra Ace® qPCR Master Mix and 
gDNA remover kit. After RNA extraction with 
Sepasol RNA I Super G, DNA was obtained by 250μl
back extraction buffer (4 M guanidine thiocyanate; 
50 mM sodium citrate; 1 M Tris, pH 8.0) into 
the phenol phase and interphase. qRT-PCR was 
performed in a StepOnePlus real-time PCR system 
(Applied Biosystems, CA, USA) using the KAPA 
SYBR® FAST qPCR kit, to evaluate specific 
mRNA content. Data were normalized to β -actin 
mRNA, and the expression levels were compared 
to the mRNA expression values in rats aged 32 
weeks. The qRT-PCR primers are listed in Table 1. 
２．５　Statistical analysis
　Data are presented as mean ± standard error 
(SE). Results were analyzed using Student’s T-test 
or subjected to one-way analysis of variance 
(ANOVA) followed by the Tukey-Kramer post-hoc 
test (Statcel4, OMS Inc., Tokyo, Japan).
Table 1. Primers used for PCR. 
 
Gene Direction Primer sequence 
β-actin (Actb)  forward 5′-GGAGATTACTGCCCTGGCTCCTA-3′ 
 reverse 5′-GACTCATGTACTCCTGCTTGCTG-3′ 
MyHC-I (Myh7) forward 5′-AGAGGAAGACAGGAAGAACCTAC-3′ 
 reverse 5′-GGCTTCACAGGCATCCTTAG-3′ 
PGC-1α (Ppargc1α) forward 5′-GACCCCAGAGTCACCAAATGA-3′ 
 reverse 5′-GGCCTGCAGTTCCAGAGAGT-3′ 
Cycs (Cycs) forward 5′-AGCGGGACGTCTCCCTAAGA-3′ 
 reverse 5′-CTTCCGCCCAAACAGACCA-3′ 
SDH (sdha) forward 5′-TGGGGCGACTCGTGGCTTTC-3′ 
 reverse 5′-ATCTCCAGTTGTCCTCTTCCA-3′ 
MuRF1 (Trim63) forward 5′-CGACTCCTGCCGAGTGACC-3′ 
 reverse 5′-GCGTCAAACTTGTGGCTCAG-3′ 
Atrogin-1 (Fbxo32) forward 5′-GAACAGCAAAACCAAAACTCAGTA′ 
 reverse 5′-CTCCTTAGTAGTACTCCCTTTGTGAA-3′ 
MtND1 (mt-Nd1) forward 5′-CTCCCTATTCGGAGCCCTAC-3′ 
 reverse 5′-ATTTGTTTCTGCTAGGGTTG-3′ 
 
 
Table 2. Aging-related changes on tissue weight of WAT (kidney), WAT (testicle), 
soleus muscle and Gas muscle in SD rats at age 32, 85 and 92 weeks.  
 
g/kg-BW 32w 85w 92w 
WAT (kidney) 19.4 ± 1.86 a 38.8 ± 3.35 b 38.3 ± 2.19 b 
WAT (testicle) 20.9 ± 1.19 a 22.5 ± 1.48 a 25.1 ± 1.04 a 
Soleus 0.70 ± 0.03 a 0.47 ± 0.04 b 0.50 ± 0.06 b 
Gas 8.89 ± 0.50 a 5.00 ± 0.33 b 5.62 ± 0.54 b 
Values shown represent means ± SE of 3-7. Results were analyzed with one-way 
ANOVA followed by the Tukey-Kramer post hoc test for multiple comparisons. Groups 
without the same letter are significantly different (p<0.05). 




３．１ 　Age-related changes in VO2 and 
spontaneous locomotor activity of 
SD rats
　Age-related changes in VO2 (mL/min/kg) and 
spontaneous locomotor activity over 20 (count/min) 
were determined and glucose oxidation rates (mg/
min/kg) were calculated during the day (10:00-
8:00) for the rats aged 32 and 90 weeks (Figure 1). 
Relative to rats aged 32 weeks, VO2 tended to be 
decreased in the rats aged 90 weeks (Figure 1A). 
As the rats aging, spontaneous locomotor activity 
also tended to be decreased in rats at the age of 
90 weeks compared to that of rats aged 32 weeks 
(Figure 1A). Glucose oxidation was decreased 
significantly in rats at age of 90 weeks relative to 
rats aged 32 weeks (Figure 1B).
３．２　Skeletal muscle function analysis
　The relative mitochondrial DNA level were 
decreased significantly in the soleus muscle of 
rats aged 85 and 92 weeks compared to that of 
rats aged 32 weeks (Figure 2A). SDH staining 
of soleus muscle was performed to characterize 
mitochondrial enzyme function and myofiber 
oxidative capacity (19,20). From the results of SDH 
staining, the soleus muscle of rats aged 85 and 92 
weeks showed a decrease in the positive staining 
level compared to that of rats aged 32 weeks 
(Figure 2B). With aging, mRNA expression of 
myosin heavy chain 7 (MyHC-I) (Myh7), PGC-1α













Figure 1. Age-related changes in VO2 (mL/min/kg), spontaneous locomotor activity over 20 
(count/min) (A), and glucose oxidation (mg/min/kg) during the day (10:00-8:00) in SD rats aged 32 
and 90 weeks. The values shown represent mean ± SE of 4-15 rats. B: The results were analyzed 














Figure 2. Age-related changes in mitochondrial function of soleus muscle.  
(A) Relative mitochondrial DNA level in soleus muscle. The results were analyzed with one-way 
ANOVA followed by the Tukey-Kramer post-hoc test for multiple comparisons. The groups without 
the same letter present a statistically significant difference (p<0.05). The values shown represent 
mean ± SE of 3-6 rats. (B) SDH staining of soleus muscle section of SD rats aged 32, 85, and 92 
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Figure 1. Age-related changes in VO2 (mL/min/kg), spontaneous locomotor activity over 20 (count/
min) (A), and gl cose oxidation (mg/min/kg) during the day (1 :00-8:00) in SD rats aged 32 and 90 
weeks. The values shown represent mean ± SE of 4-15 rats. B: The results were analyzed using 
Student’s t-test. Statistical differences are shown as **p<0.01.
Figure 2. Age-related changes in mitochondrial function of soleus muscle. 
(A) Relative mitochondrial DNA level in soleus muscle. The results were analyzed with one-
way ANOVA followed by the Tukey-Kramer post-hoc test for multiple comparisons. The groups 
without the same l tt r present a sta istically significant differenc  (p<0.05). The values shown 
represent mean ± SE of 3-6 rats. (B) SDH staining of soleus muscle section of SD rats aged 32, 
85, and 92 weeks. Magnification: × 100; Scale bar: 50 μ m
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(sdha) decreased significantly in the soleus muscle 
of rats aged 85 and 92 weeks compared to that 
of rats aged 32 weeks (Figure 3). Expression of 
MuRF1 (Trim63) and Atrogin-1 (Fbxo32) mRNA 
increased significantly in the soleus muscle of rats 
aged 85 and 92 weeks compared to that of rats 
aged 32 weeks.
３．３　Lipid accumulation in tissues
　As shown in Table 2, weight of WAT around 
the kidney increased significantly in the rats aged 
85 weeks (38.8 ± 3.35 g/kg) and 92 weeks (38.3 ± 
2.19 g/kg) compared to that in rats aged 32 weeks 
(19.4 ± 1.86 g/kg). The weight of WAT around the 
testicle increased, but not statistically significant, 
in rats aged 85 and 92 weeks, compared to that 
in rats aged 32 weeks. The mass of soleus muscle 
decreased significantly in rats aged 85 weeks (0.47 
± 0.04 g/kg) and 92 weeks (0.50 ± 0.06 g/kg) 
compared to that in rats aged 32 weeks (0.70 ± 
0.03 g/kg). The mass of Gas muscle also decreased 
significantly in rats aged 85 weeks (5.00 ± 0.33 g/
kg) and 92 weeks (5.62 ± 0.54 g/kg) compared 
to that in rats aged 32 weeks (8.89 ± 0.50 g/kg). 
As rats aged, the level of plasma FFA (mEq/
L) increased significantly in rats aged 50 to 92 
weeks compared to that in rats aged 32 weeks 
(Figure 4A). The level of plasma cholesterol (mg/
Table 1. Primers used for PCR. 
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β-actin (Actb)  forward 5′-GGAGATTACTGCCCTGGCTCCTA-3′ 
 reverse 5′-GACTCATGTACTCCTGCTTGCTG-3′ 
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PGC-1α (Ppargc1α  forward 5′-GACCCCAGAGTCACCAAATGA-3′ 
 reverse 5′-GGCCTGCAGTTCCAGAGAGT-3′ 
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SDH (sdha) forward 5′-TGGGGCGACTCGTGGCTTTC-3′ 
 reverse 5′-ATCTCCAGTTGTCCTCTTCCA-3′ 
MuRF1 (Trim63) forward 5′-CGACTCCTGCCGAGTGACC-3′ 
 reverse 5′-GCGTCAAACTTGTGGCTCAG-3′ 
Atrogin-1 (Fbxo32) forward 5′-GAACAGCAAAACCAAAACTCAGTA′ 
 reverse 5′-CTCCTTAGTAGTACTCCCTTTGTGAA-3′ 
MtND1 (mt-Nd1) forward 5′-CTCCCTATTCGGAGCCCTAC-3′ 
 reverse 5′-ATTTGTTTCTGCTAGGGTTG-3′ 
 
 
Table 2. Aging-related changes on tissue weight of WAT (kidney), WAT (testicle), 
soleus muscle and Gas muscle in SD rats at age 32, 85 and 92 weeks.  
 
g/kg-BW 32w 85w 92w 
WAT (kidney) 19.4 ± 1.86 a 38.8 ± 3.35 b 38.3 ± 2.19 b 
WAT (testicle) 20.9 ± 1.19 a 22.5 ± 1.48 a 25.1 ± 1.04 a 
Soleus 0.70 ± 0.03 a 0.47 ± 0.04 b 0.50 ± 0.06 b 
Gas 8.89 ± 0.50 a 5.00 ± 0.33 b 5.62 ± 0.54 b 
Values shown represent means ± SE of 3-7. Results were analyzed with one-way 
ANOVA followed by the Tukey-Kramer post hoc test for multiple comparisons. Groups 
without the same letter are significantly different (p<0.05). 
Figure 3. Age-related changes in relative mRNA expression levels of MyHC-I (Myh7), PGC-1α 
(Ppargc1α), Cycs (Cycs), SDH (sdha), MuRF1 (Trim63), and Atrogin-1 (Fbxo32) in soleus muscle of SD 
rats aged 32, 85, and 92 weeks. 
The values shown represent mean ± SE of 3-6 rats. The results were analyzed with one-way 
ANOVA followed by the Tukey-Kramer post-hoc test for multiple comparisons. The groups without 
the same letter present a statistically significant difference (p<0.05).
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Figure 4. Age-related changes in plasma FFA and cholesterol in SD rats aged 32 to 92 weeks.  
(A) Plasma FFA level (mEq/L), (B) Plasma cholesterol level (mg/dL). The values shown represent 
mean ± SE of 3-12 rats. The results were analyzed with one-way ANOVA followed by the Tukey-
Kramer post-hoc test for multiple comparisons. The groups without the same letter represent a 





dL) tended to increase in rats during the aging 
process (Figure 4B). The results of H&E staining 
and Oil-Red O staining, age-related changes in the 
soleus muscle in SD rats, are shown in Figure 5. 
The tissue sections with Oil-Red O staining in rats 
aged 85 weeks showed more lipid accumulation 
and it of 92 weeks showed a marked increase in 




　As rats aging, the VO2 tended to be decreased 
in rats at the age of 90 weeks compared to that 
of rats aged 32 weeks (Figure 1A). This suggests 
that the aging process might contribute to 
decline in O2 consumption, which is indicated 
as a typical age-related change. In a study in 
humans, Rivera reported that VO2max was lower 
in master runners than in young runners because 
of a diminished capacity to deliver and extract 
O2 during exercise, in master runners (8). In 
this study, with advancing age, the spontaneous 
locomotor activity tended to be decreased in rats 
at the age of 90 weeks compared to that of rats 
aged 32 weeks (Figure 1A). In a previous study, 
aged rats (24-27 months old) consistently presented 
lower spontaneous locomotor activity compared to 
young rats (3-6 months old), during the dark cycle 
(20:00-8:00) (10). In another study, aged F344 rats 
showed 75-80% reduction in locomotor activity 
compared to young rats (21). This indicates that 
the loss of spontaneous locomotor activity is an 
unavoidable phenomenon and a characteristic of 
the aging process. In this study, glucose oxidation 
was also decreased significantly from 32 to 90 
weeks (Figure 1B), which indicates that energy 
metabolism through glucose oxidation might be 
decreased with age. Rooyackers showed that a 
significant decline in oxidative capacity occurred 
in skeletal muscle with aging (22), which might 
explain the decline in glucose oxidation in the 
skeletal muscles of rats in this study, and might 
also explain the decrease in VO2 and spontaneous 
locomotor activity of the aged rats.
　Age-related muscle weakness and reduced 
aerobic capacity result not only in diminished 
physical performance, but also in metabolic 
disorders in humans (23,24). Reduced muscle 
mitochondrial function could contribute to age-
related muscle dysfunction and reduced aerobic 
capacity (11). In this study, it was observed that the 
relative mitochondrial DNA level was decreased 
significantly in the soleus muscle of rats aged 85 
and 92 weeks compared to that of rats aged 32 
weeks (Figure 2A). SDH activity is a performance 
for mitochondrial oxidative capacity (19,25), and 
SDH staining results showed that mitochondrial 
oxidative capacity decreased in the soleus muscle 
of rats aged 85 and 92 weeks compared to that 
Figure 4. Age-related changes in plasma FFA and cholesterol in SD rats aged 32 to 92 weeks. 
(A) Plasma FFA level (mEq/L), (B) Plasma cholesterol level (mg/dL). The values shown represent 
mean ± SE of 3-12 rats. The results were analyzed with one-way ANOVA followed by the Tukey-
Kramer post-hoc test for multiple comparisons. The groups without the same letter represent a 
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of rats aged 32 weeks (Figure 2B). Ermini et al. 
showed that SDH activity decreases in the muscles 
of old rats as compared to young rats (26). Myosin 
heavy chain is an essential component of skeletal 
muscle and is associated with skeletal muscle 
contraction function (23, 27, 28). With advancing 
age, relative mRNA expression levels of PGC-1α, 
Cycs, and SDH decreased significantly in the soleus 
muscle of rats aged 85 and 92 weeks, compared 
to that of rats aged 32 weeks (Figure 3). PGC-1α 
plays a major role in metabolic regulation (29, 30), 
oxidative capacity (31), and regulation of respiration 
in skeletal muscle (32). Dillon also showed that 
during aging, there is a decrease in PGC-1α
expression in the heart and skeletal muscles 
(33). Cycs is essential for energy production and 
mitochondrial respiration, as a component of the 
electron transport chain and as a mitochondrial 
marker protein (34, 35). The results of this study 
showed that the aging process might contribute to 
age-related decline of mRNA expression involved 
in mitochondrial oxidative function. Atrogin-1 
and MuRF-1 have been identified as important 
enzymes in muscle atrophy, and regulation of their 
expression has the potential to prevent or reverse 
muscle atrophy in patients with sarcopenia (36). In 
this study, the relative mRNA expression levels of 
MuRF1 and Atrogin-1 were increased significantly 
in the soleus muscle of rats aged 85 and 92 weeks 
compared to that of rats aged 32 weeks.
Aging is also associated with the dysregulation of 
lipid metabolism. In this study, the weight of WAT 
around the kidney was increased significantly and 
skeletal muscle mass was decreased significantly 
in rats aged 85 and 92 weeks compared to that in 
rats aged 32 weeks (Table 2). Previous research 
by Honma et al. found that the weight of WAT 
(epididymal, mesenteric, and perirenal) was 
increased significantly with aging in SAMP10 
mice (15). As per previous studies, a typical adult 
will lose muscle mass with age and lead to a 
reduction in muscle function (2), referred to as 
sarcopenia of aging (24). In this study, Oil-Red O 
staining results showed that lipid accumulation 
was also increased in the soleus muscle of SD rats 
aged 92 weeks compared to that of rats aged 32 
weeks (Figure 5). FFA level in the plasma was also 
increased significantly as the rats aged (Figure 4). 
In a previous study, plasma FFA was increased 
significantly in mice aged 6 months and 12 months, 
compared to that in mice aged 3 months (15). 
Elderly humans subjects (71+2 yr old) displayed 
higher plasma FFA levels (897 ± 107 µmol/L vs. 412 
± 50 µmol/L, p<0.01) in the basal state compared 
to younger subjects (21+2 yr old) (37). In this 
study, plasma cholesterol level of aged rats was 
tended to increase. Alessio found that usual age-
related physiological changes include increased 














Figure 5. Age-related changes in H&E and Oil-Red O staining of soleus muscle of SD rats aged 32, 





























Figure 5. Age-related changes in H&E and Oil-Red O staining of soleus muscle of SD rats aged 32, 
85, and 92 weeks. Magnification: × 100; Scale bar: 50 μm
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lean body mass, and loss of bone density (38). In 
another study, serum cholesterol levels in SD rats 
increased sharply in 24 months (173 ± 85 mg/dL), 
and the levels of serum cholesterol was tended to 
increase with age in primates (39). It is suggested 
that the aging process might contribute to the 
decline of muscle mass, and to the increase in lipid 
accumulation in the body.
　In summary, the aging process might contribute 
to a decline in O2 consumption, spontaneous 
locomotor activity, glucose oxidation, skeletal 
muscle mass and function, and mitochondrial 
oxidative capacity in skeletal muscle in rats. In 
addition, lipid accumulation in skeletal muscle, 
weight of WAT, and levels of FFA were increased 
with age, in rats. In order to delay the age-related 
changes in muscle function and lipid accumulation 
in body, it is important to maintain or improve 
mitochondrial function in the skeletal muscle. This 
study may contribute to the understanding of 
age-related changes in rats and could provide a 
potential perspective for future anti-aging research, 
for coping with the concern of a rapidly growing 
aging population.
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